페퍼민트 오일 관련 과민성 대장 증후군(IBS)
A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.12건 이상의 RCT 메타분석에서 페퍼민트 오일(장용코팅, 450~750mg/일)이 IBS 복통을 유의하게 감소시키는 것으로 나타났습니다(RR 1.78 대 위약). 전반적인 IBS 증상 개선에 대해 A등급 근거이며 ACG 조건부 권장입니다.
결론
12건 이상의 RCT 메타분석에서 페퍼민트 오일(장용코팅, 450~750mg/일)이 IBS 복통을 유의하게 감소시키는 것으로 나타났습니다(RR 1.78 대 위약). 전반적인 IBS 증상 개선에 대해 A등급 근거이며 ACG 조건부 권장입니다.
Key Study Findings
대상 집단: patients with IBS (review of plant extracts including peppermint oil, Iberogast, curcumin)
대상 집단: Patients with functional bloating/distension (consensus)
대상 집단: Patients with functional dyspepsia and IBS (review)
대상 집단: Review of herbal remedies for IBS
대상 집단: Patients with IBS (review)
대상 집단: Patients with irritable bowel syndrome
Key Statistics
19
연구
2569
참여자
Positive
등급
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 450-750 mg/day enteric-coated capsules
- ibssymptomsupport:
- 187-225 mg enteric-coated capsules, 2-3 times daily, 30-60 min before meals
상한량: Well-tolerated up to 1,200 mg/day in clinical trials; enteric coating essential
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
권장 복용 시간: 30-60 minutes before meals; enteric-coated capsules MUST be swallowed whole (do not chew or crush)
Safety & Side Effects
보고된 부작용
- ⚠ Heartburn/GERD exacerbation (if non-enteric-coated; relaxes lower esophageal sphincter)
- ⚠ Perianal burning sensation (from undigested menthol reaching the rectum)
- ⚠ Nausea at high doses
- ⚠ Allergic reactions in mint-sensitive individuals
알려진 상호작용
- ● Cyclosporine (peppermint may increase cyclosporine levels via CYP3A4 inhibition)
- ● Antacids and PPIs (may dissolve enteric coating prematurely; space 2 hours)
- ● Simethicone (coated formulations may interact with enteric-coated peppermint)
- ● CYP2C19 substrates (menthol is a weak CYP inhibitor)
일일 최대 섭취 허용량: Well-tolerated up to 1,200 mg/day in clinical trials; enteric coating essential
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does 페퍼민트 오일 help with 과민성 대장 증후군(IBS)?
How much 페퍼민트 오일 should I take for 과민성 대장 증후군(IBS)?
Are there side effects of 페퍼민트 오일?
How strong is the evidence for 페퍼민트 오일 and 과민성 대장 증후군(IBS)?
Related Evidence
관련 다른 성분: 과민성 대장 증후군(IBS)
References
- [1] Ploutarchos Pastras et al.. Nutrients. 2026. Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines. doi:10.3390/nu18020183 PubMed
- [2] Sheida Zeraattalab-Motlagh et al.. Nutr Rev. 2025. Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical … doi:10.1093/nutrit/nuae107 PubMed
- [3] Giovanni Marasco et al.. J Clin Med. 2025. Functional Foods and Nutraceuticals in Irritable Bowel Syndrome. doi:10.3390/jcm14061830 PubMed
- [4] Chloé Melchior et al.. United European Gastroenterol J. 2025. European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management. doi:10.1002/ueg2.70098 PubMed
- [5] Md Moniruzzaman et al.. Dig Liver Dis. 2025. Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction. doi:10.1016/j.dld.2025.07.010 PubMed
- [6] Zoe N Memel et al.. Nutr Clin Pract. 2025. Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome. doi:10.1002/ncp.11307 PubMed
- [7] Raquel Abalo et al.. Int J Mol Sci. 2025. Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies. doi:10.3390/ijms26199345 PubMed
- [8] Sophie Brigstocke et al.. Gastroenterol Hepatol (N Y). 2025. Natural Products for the Treatment of Irritable Bowel Syndrome. PubMed
- [9] . Med Lett Drugs Ther. 2025. Drugs for irritable bowel syndrome. doi:10.58347/tml.2025.1721a PubMed
- [10] Silvia Salvatore et al.. Nutrients. 2024. Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights. doi:10.3390/nu16030349 PubMed
- [11] Sandra Utz et al.. Z Gastroenterol. 2024. [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review]. doi:10.1055/a-2279-5045 PubMed
- [12] Kei Matsueda et al.. Biopsychosoc Med. 2024. Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and … doi:10.1186/s13030-024-00302-y PubMed
- [13] Emidio Scarpellini et al.. Curr Pharm Des. 2023. The Use of Peppermint Oil in Gastroenterology. doi:10.2174/1381612829666230328163449 PubMed
- [14] Daniela Pop et al.. Nutrients. 2023. The Use of Fibers, Herbal Medicines and Spices in Children with Irritable Bowel Syndrome: A Narrative Review. doi:10.3390/nu15204351 PubMed
- [15] Maria Rosa Ingrosso et al.. Aliment Pharmacol Ther. 2022. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. doi:10.1111/apt.17179 PubMed
- [16] Andrew Thomas et al.. Am J Lifestyle Med. 2022. Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome. doi:10.1177/15598276211012968 PubMed
- [17] Joanna Giang et al.. Nutr Diet. 2022. Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review … doi:10.1111/1747-0080.12672 PubMed
- [18] Joelle BouSaba et al.. Neurogastroenterol Motil. 2022. Pain in irritable bowel syndrome: Does anything really help? doi:10.1111/nmo.14305 PubMed
- [19] Yu Gu et al.. Aliment Pharmacol Ther. 2022. Letter: efficacy of peppermint oil in irritable bowel syndrome. doi:10.1111/apt.17194 PubMed
- [20] Maria Rosa Ingrosso et al.. Aliment Pharmacol Ther. 2022. Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply. doi:10.1111/apt.17197 PubMed
- [21] Christopher J Black et al.. Frontline Gastroenterol. 2021. Best management of irritable bowel syndrome. doi:10.1136/flgastro-2019-101298 PubMed
- [22] Judy Nee et al.. Am J Gastroenterol. 2021. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. doi:10.14309/ajg.0000000000001395 PubMed
- [23] Christopher J Black et al.. Lancet Gastroenterol Hepatol. 2020. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. doi:10.1016/S2468-1253(19)30324-3 PubMed
- [24] Zsa Zsa R M Weerts et al.. Gastroenterology. 2020. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. doi:10.1053/j.gastro.2019.08.026 PubMed
- [25] Karin Ried et al.. Nutr Res. 2020. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. doi:10.1016/j.nutres.2020.02.008 PubMed
- [26] Jason A Hawrelak et al.. Complement Ther Med. 2020. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. doi:10.1016/j.ctim.2019.102233 PubMed
- [27] Eirini Dimidi et al.. Neurogastroenterol Motil. 2020. Food supplements and diet as treatment options in irritable bowel syndrome. doi:10.1111/nmo.13951 PubMed
- [28] Christopher J Black et al.. Gastroenterology. 2020. Peppermint Oil in Irritable Bowel Syndrome. doi:10.1053/j.gastro.2019.09.055 PubMed
- [29] Christopher N Andrews et al.. J Can Assoc Gastroenterol. 2020. Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update. doi:10.1093/jcag/gwz034 PubMed
- [30] . Med Lett Drugs Ther. 2020. Drugs for Irritable Bowel Syndrome. PubMed
- [31] Paul Moayyedi et al.. J Can Assoc Gastroenterol. 2019. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). doi:10.1093/jcag/gwy071 PubMed
- [32] N Alammar et al.. BMC Complement Altern Med. 2019. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. doi:10.1186/s12906-018-2409-0 PubMed
- [33] Akhil Munjal et al.. Curr Gastroenterol Rep. 2019. Update on Pharmacotherapy for Irritable Bowel Syndrome. doi:10.1007/s11894-019-0692-7 PubMed
- [34] Liang Dai et al.. World J Clin Cases. 2019. Irritable bowel syndrome and functional constipation management with integrative medicine: A systematic review. doi:10.12998/wjcc.v7.i21.3486 PubMed
- [35] B P Chumpitazi et al.. Aliment Pharmacol Ther. 2018. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional … doi:10.1111/apt.14519 PubMed
- [36] Amanda C Fifi et al.. Nutrients. 2018. Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials. doi:10.3390/nu10111715 PubMed
- [37] Diego Currò et al.. Br J Pharmacol. 2017. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. doi:10.1111/bph.13632 PubMed
- [38] Emma P Halmos. J Gastroenterol Hepatol. 2017. When the low FODMAP diet does not work. doi:10.1111/jgh.13701 PubMed
- [39] Eirini Dimidi et al.. Curr Opin Clin Nutr Metab Care. 2017. Irritable bowel syndrome and diet: where are we in 2018? doi:10.1097/MCO.0000000000000416 PubMed
- [40] Brent W Acker et al.. Curr Gastroenterol Rep. 2017. Medicinal Foods for Functional GI Disorders. doi:10.1007/s11894-017-0601-x PubMed
- [41] Miguel Saps et al.. Handb Exp Pharmacol. 2017. Gastrointestinal Pharmacology. doi:10.1007/164_2016_119 PubMed
- [42] Stacy L Haber et al.. Am J Health Syst Pharm. 2016. Peppermint oil for treatment of irritable bowel syndrome. doi:10.2146/ajhp140801 PubMed
- [43] Reena Khanna et al.. J Clin Gastroenterol. 2014. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. doi:10.1097/MCG.0b013e3182a88357 PubMed
- [44] Oliver Grundmann et al.. World J Gastroenterol. 2014. Complementary and alternative medicines in irritable bowel syndrome: an integrative view. doi:10.3748/wjg.v20.i2.346 PubMed
- [45] Katy E Trinkley et al.. Digestion. 2014. Medication management of irritable bowel syndrome. doi:10.1159/000362405 PubMed
- [46] Tim Vanuytsel et al.. J Gastroenterol. 2014. Treatment of abdominal pain in irritable bowel syndrome. doi:10.1007/s00535-014-0966-7 PubMed
- [47] V I Pilipenko et al.. Vopr Pitan. 2013. [Contemporary dietotherapy of the irritable bowel syndrome]. PubMed
- [48] Julia Fashner et al.. FP Essent. 2013. Common gastrointestinal symptoms: irritable bowel syndrome. PubMed
- [49] Alexander Charles Ford et al.. BMJ Clin Evid. 2012. Irritable bowel syndrome. PubMed
- [50] K E Trinkley et al.. J Clin Pharm Ther. 2011. Treatment of irritable bowel syndrome. doi:10.1111/j.1365-2710.2010.01177.x PubMed
- [51] Nicole C Suares et al.. Discov Med. 2011. Diagnosis and treatment of irritable bowel syndrome. PubMed
- [52] Paul Enck et al.. Eur J Gastroenterol Hepatol. 2010. Therapy options in irritable bowel syndrome. doi:10.1097/MEG.0b013e3283405a17 PubMed
- [53] Alexander Charles Ford et al.. BMJ Clin Evid. 2010. Irritable bowel syndrome. PubMed
- [54] Yi-Hao A Shen et al.. Can Fam Physician. 2009. Complementary and alternative medicine for treatment of irritable bowel syndrome. PubMed
- [55] Full-Young Chang et al.. J Chin Med Assoc. 2009. Treatment of irritable bowel syndrome using complementary and alternative medicine. doi:10.1016/S1726-4901(09)70375-2 PubMed
- [56] Marie Pirotta. Aust Fam Physician. 2009. Irritable bowel syndrome - The role of complementary medicines in treatment. PubMed
- [57] Alexander C Ford et al.. BMJ. 2008. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. doi:10.1136/bmj.a2313 PubMed
- [58] Benjamin Kligler et al.. Am Fam Physician. 2007. Peppermint oil. PubMed
- [59] Diane L McKay et al.. Phytother Res. 2006. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). doi:10.1002/ptr.1936 PubMed
- [60] Howard Y Chang et al.. Curr Treat Options Gastroenterol. 2006. Current gut-directed therapies for irritable bowel syndrome. doi:10.1007/s11938-006-0013-8 PubMed
- [61] Theresa L Charrois et al.. Pediatr Rev. 2006. Peppermint oil. doi:10.1542/pir.27-7-e49 PubMed
- [62] H G Grigoleit et al.. Phytomedicine. 2005. Peppermint oil in irritable bowel syndrome. doi:10.1016/j.phymed.2004.10.005 PubMed
- [63] Susan K Hadley et al.. Am Fam Physician. 2005. Treatment of irritable bowel syndrome. PubMed
- [64] M H Pittler et al.. Am J Gastroenterol. 1998. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. doi:10.1111/j.1572-0241.1998.00343.x PubMed
- [65] T R Koch. Am J Gastroenterol. 1998. Peppermint oil and irritable bowel syndrome. doi:10.1111/j.1572-0241.1998.02304.x PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.